1180672-84-7

Basic information

• Product Name: 3-hydroxy-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid
• Synonyms: 3-hydroxy-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid
• CAS NO: 1180672-84-7
• Molecular Weight: 264.173
• Mol File: 1180672-84-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-hydroxy-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-hydroxy-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid(1180672-84-7)
• EPA Substance Registry System: 3-hydroxy-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid(1180672-84-7)

Safety Data

• Hazardous Substances Data: 1180672-84-7(Hazardous Substances Data)

Upstream product

• 1180675-98-2 3-bromo-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid 
• 1005514-85-1 3-amino-5-pentafluorosulfanylbenzoic acid 
• 852469-45-5 3-nitro-5-(pentafluoro-λ⁶-sulfanyl)benzoic acid 
• 833-96-5 3-(pentafluoro-λ⁶-sulphanyl)benzoic acid 

Downstream Products

• 1178585-21-1 methyl 3-methoxy-5-(pentafluorosulfanyl)benzoate 
• 1178584-08-1 2-bromo-1-[3-methoxy-5-(pentafluorosulfanyl)phenyl]ethanone 
• 1448315-53-4 3-hydroxy-N-{4-methyl-3-[6-(pyridin-3-yl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl}-5-(pentafluoro-λ⁶-sulphanyl)benzamide 
• 1448315-58-9 N-{4-methyl-3-[6-(pyridin-3-yl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl}-3-(pentafluoro-λ⁶-sulphanyl)-5-(pyrrolidin-3-yloxy)benzamide 
• 1211582-83-0 3-methoxy-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid 
• 1448317-63-2 3-{2-[(tert-butoxycarbonyl)amino]ethoxy}-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid 
• 1448317-64-3 3-{3-[(tert-butoxycarbonyl)amino]propoxy}-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid 
• 1448317-65-4 3-{[1-(tert-butoxycarbonyl)azetidin-3-yl]oxy}-5-(pentafluoro-λ⁶-sulphanyl)benzoic acid 

Relevant articles and documents

Substituted phenylimidazopyrazoles and their use

The present application relates to novel 1-phenyl-1H-imidazo[1,2-b]pyrazole derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular angiogenic disorders and hyperproliferative disorders, where neovascularization plays a role, such as, for example, neoplastic disorders and tumour disorders. Such treatments can be carried out as monotherapy or else in combination with other medicaments or further therapeutic measures.

TRIAZOLIUM SALTS AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS

The invention relates to novel compounds of formula I where X, A?, Q1, Q2 Q3, R2, R3, R4, R5, R6, R7, R8 and R9 are each as defined below. The compounds of formula I have antithrombotic activity and inhibit especially protease-activated recepto